ANDREW MOLNAR — Lobbyist Profile | Poliscope

ANDREW MOLNAR

Reported covered position: N/A

Filings

Clients

Firms

Years active

2021–2023

Associated filing income

—

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
DIGITAL THERAPEUTICS ALLIANCE, INC	8	2021–2023

Lobbying firms

Firm	Filings	Years
DIGITAL THERAPEUTICS ALLIANCE, INC	8	2021–2023

Bills explicitly cited in this lobbyist’s assigned issues (16)

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

H.R. 1458

Access to Prescription Digital Therapeutics Act of 2023

Client: DIGITAL THERAPEUTICS ALLIANCE, INC · Firm: DIGITAL THERAPEUTICS ALLIANCE, INC

Open original LDA filing ↗

Cited source text

H.R.1458/S.723

H.R. 1458

Access to Prescription Digital Therapeutics Act of 2023

Client: DIGITAL THERAPEUTICS ALLIANCE, INC · Firm: DIGITAL THERAPEUTICS ALLIANCE, INC

Open original LDA filing ↗

Cited source text

H.R.1458/S.723

Original LDA source filings (8)

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

DIGITAL THERAPEUTICS ALLIANCE, INC via DIGITAL THERAPEUTICS ALLIANCE, INC

2023 · first_quarter · Q1

Firm income: —Client expense: $58,090Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

MMM

Medicare/Medicaid

H.R.1458/S.723

HCR

Health Issues

H.R.1458/S.723

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

DIGITAL THERAPEUTICS ALLIANCE, INC via

Source: Senate LDA

Show 4 more original filings

DIGITAL THERAPEUTICS ALLIANCE, INC via DIGITAL THERAPEUTICS ALLIANCE, INC

2022 · third_quarter · 3A

Firm income: —Client expense: $97,466Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

H.R.7051 - Access to Prescription Digital Therapeutics Act of 2022 S.3791 - Access to Prescription Digital Therapeutics Act of 2022

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

DIGITAL THERAPEUTICS ALLIANCE, INC via DIGITAL THERAPEUTICS ALLIANCE, INC

2022 · second_quarter · 2A

Firm income: —Client expense: $114,015Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

H.R.7051 - Access to Prescription Digital Therapeutics Act of 2022 S.3791 - Access to Prescription Digital Therapeutics Act of 2022

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

DIGITAL THERAPEUTICS ALLIANCE, INC via DIGITAL THERAPEUTICS ALLIANCE, INC

2022 · first_quarter · 1A

Firm income: —Client expense: $30,862Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

H.R.7051 - Access to Prescription Digital Therapeutics Act of 2022 S.3791 - Access to Prescription Digital Therapeutics Act of 2022

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

DIGITAL THERAPEUTICS ALLIANCE, INC via DIGITAL THERAPEUTICS ALLIANCE, INC

2021 · fourth_quarter · RR

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

INS

Insurance

Current scope is a focus on Medicare payment pathways for Software As A Medical Device as defined by the FDA, or "Digital Therapeutics" as they are further defined for clinically validated software to treat a disease or disorder. This will include discussions on M.C.I.T and various legislation leading towards potential coverage for these novel treatments.

MMM

Medicare/Medicaid

ALC